Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry

Last updated: February 17, 2025
Sponsor: University Hospital, Basel, Switzerland
Overall Status: Active - Recruiting

Phase

N/A

Condition

Chest Pain

Cardiac Disease

Dysrhythmia

Treatment

catheter-based ablation of atrial fibrillation (pulmonary vein isolation)

Clinical Study ID

NCT03718364
2018-00226; me18Kuehne2
  • Ages > 18
  • All Genders

Study Summary

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients undergoing catheter-based ablation of atrial fibrillation (pulmonary veinisolation)

Exclusion

Exclusion Criteria:

  • Patients not able or willing to participate in this study

Study Design

Total Participants: 3000
Treatment Group(s): 1
Primary Treatment: catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Phase:
Study Start date:
July 01, 2010
Estimated Completion Date:
December 31, 2035

Connect with a study center

  • Cardiology/Electrophysiology, University Hospital Basel

    Basel, 4031
    Switzerland

    Active - Recruiting

  • University Hospital Bern

    Bern, 3010
    Switzerland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.